Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
453.80
+20.91 (4.83%)
At close: Sep 8, 2025, 4:00 PM
453.00
-0.80 (-0.18%)
After-hours: Sep 8, 2025, 5:13 PM EDT
Madrigal Pharmaceuticals Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$463.78
Upside
+2.20%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $500 | Strong Buy | Initiates | $500 | +10.18% | Sep 4, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $390 → $554 | Strong Buy | Maintains | $390 → $554 | +22.08% | Aug 26, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $483 → $485 | Buy | Maintains | $483 → $485 | +6.88% | Aug 20, 2025 |
| UBS | UBS | Strong Buy Maintains $458 → $523 | Strong Buy | Maintains | $458 → $523 | +15.25% | Aug 12, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $420 → $428 | Strong Buy | Maintains | $420 → $428 | -5.69% | Aug 6, 2025 |
| UBS | UBS | Strong Buy Maintains $441 → $458 | Strong Buy | Maintains | $441 → $458 | +0.93% | May 2, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $422 → $460 | Strong Buy | Reiterates | $422 → $460 | +1.37% | May 2, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $394 → $420 | Strong Buy | Maintains | $394 → $420 | -7.45% | May 2, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $443 | Buy | Reiterates | $443 | -2.38% | Apr 24, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $378 → $469 | Strong Buy | Maintains | $378 → $469 | +3.35% | Feb 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $400 → $405 | Strong Buy | Maintains | $400 → $405 | -10.75% | Feb 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $390 → $400 | Strong Buy | Maintains | $390 → $400 | -11.86% | Jan 14, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $427 | Buy | Reiterates | $427 | -5.91% | Jan 10, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 20, 2024 |
| B. Riley Securities | B. Riley Securities | Hold Maintains $194 → $236 | Hold | Maintains | $194 → $236 | -47.99% | Nov 5, 2024 |
| UBS | UBS | Strong Buy Maintains $411 → $441 | Strong Buy | Maintains | $411 → $441 | -2.82% | Nov 1, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.